Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
Cancer|January 15, 1986
Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusionJ M Koeller, D L Trump, K D Tutsch, et al.
Cancer|November 1, 1978
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trialG Falkson, C G Moertel, P Lavin, et al.
Cancer|May 1, 1978
Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophinT P Waalkes, C W Gehrke, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancerC L Loprinzi, D C Tormey, P Rasmussen, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancerF J Cummings, R Gray, T E Davis, et al.
American Journal of Clinical Oncology|June 17, 2000
21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literatureT Saphner, E A Weller, D C Tormey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1975
Breast scintigraphy with 99mTc-pertechnetate and 67Ga-citrateS D Richman, P A Brodey, R S Frankel, et al.
Journal of the National Cancer Institute|May 15, 1996
Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancerR M Hansen, L Ryan, T Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III studyH C Falkson, R Gray, W H Wolberg, et al.
Pageof 22